TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.00$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+61.9% +76.3% +49.1% +36.0% +31.8% +11.6%
-21.6% -33.1% -100.0% +128.3% +137.9% +35.2% +4.6% +36.4% +24.3%
+42.1% +46.8% +59.9% +56.5% +29.7% +5.7%
-39.0% -46.9% -3.0% -38.8% -56.7% +19.9% +226.6% +128.8% -40.5% +4.4%
-28.8% -31.5% +504.8% +0.0% +236.9% +20.5% +10.0% +20.9% +20.2% +16.6%
-35.6% -41.3% +204.0% +253.1% +52.0% -47.4% +54.3% +22.3% +14.2% +6.3%
+821.6% +32.1% -86.7% +551.6% +52.1% +35.4% +5.1%
+0.0% -7,896.8% -23,218.5% -45.5% +126.2% +85.3% +277.3% +2.0%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?